معرفی
Narges Baniasadi serves as an Adjunct Professor in the Department of Medicine at Stanford University School of Medicine, where she teaches impact entrepreneurship focused on Prevention and Health Equity. She is the founder and executive director of Stanford's Emergence program, developing educational and translational initiatives to improve societal health through entrepreneurial solutions.
Her research spans critical interdisciplinary domains:
- Health Entrepreneurship
- Health Equity
- Bioinformatics
- Artificial Intelligence in Healthcare
- Genomics
- Cancer Research
With over a decade of leadership at the technology-life sciences intersection, she founded Bina—a bioinformatics company that pioneered high-performance computing and AI platforms for cancer genomics analysis—based on research conducted at Stanford and UC Berkeley. Following Roche's acquisition of Bina, she served as VP of Informatics at Roche Sequencing until 2018, directing clinical software development and AI research.
No scientific awards, student advising records, or research grants are documented in the source material. Her current work centers on the Emergence program, which cultivates innovation in health entrepreneurship and societal health improvement through translational educational frameworks.
